赛默飞世尔Oncomine Dx靶向检测获FDA批准作为伴随诊断，用于识别适合非小细胞肺癌最新靶向疗法的患者 - 商业资讯

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer  Business Wire